In terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the trading period for buying or selling of Company’s shares is closed from Sunday, 1st January 2023 and shall reopen on Friday, 10th February 2023 i.e. after the approval & declaration of Unaudited financial results for third quarter & nine months ended 31st December 2022 by the Board of Directors at its meeting scheduled to be held on Tuesday,7th February 2023.
The above information is a part of company’s filings submitted to BSE.
